ELTP Insider Trading Activity and SEC Form 4 Filings
ELTP insider trading summary
Over the past 12 months, insiders at Elite Pharmaceuticals Inc (ELTP) reported 1 open-market purchase worth $26K by 1 insider and no sales on SEC Form 4. Net insider buying was $26K.
Latest ELTP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Barry H Dash | Director | Buy | $26K (100,000 @ $0.26) |
| Oct 2, 2025 | Douglas Plassche | EVP Operations | Sell | $499K (800,000 @ $0.62) |
| Aug 22, 2025 | Elite Pharmaceuticals Inc | EVP Operations | Sell | $262K (500,000 @ $0.52) |
| Jul 10, 2025 | Kirko Kirkov | Chief Commercial Officer | Buy | $10K (16,366 @ $0.59) |
| Jul 8, 2025 | Douglas Plassche | EVP Operations | Sell | $116K (200,000 @ $0.58) |
| Oct 24, 2024 | Douglas Plassche | SVP of Operations | Sell | $170K (333,932 @ $0.51) |
| Oct 23, 2024 | Douglas Plassche | SVP of Operations | Sell | $392K (800,000 @ $0.49) |
| Mar 18, 2016 | Jerry Treppel | Insider | Sell | $88K (258,090 @ $0.34) |
| Mar 17, 2016 | Jerry Treppel | Insider | Sell | $108K (312,430 @ $0.34) |
| Feb 24, 2016 | Jerry Treppel | Insider | Sell | $31K (100,456 @ $0.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.